• English
  • 简体中文
  • 繁體中文
  • Tiếng Việt
  • ไทย
  • Indonesia
Subscribe
Real-time News
September 2nd - US President Trump: Now that we Americans control it, should we rename the Strait of Hormuz to "Trump Strait"? Like the US itself, it will be "hotter" than ever before!On September 2nd, Bank of Canada Governor Macklem stated at a press conference that Canadas current inflation level remains too high, primarily concentrated in gasoline and energy prices. Macklem pointed out that the greater risk to current inflation lies in the evolution of the situation in the Middle East, how long oil prices will remain high, and how high they will ultimately rise. The central bank will closely monitor inflation data and make policy decisions accordingly. He stated that the central bank has limited tolerance for high inflation, and if inflation is deemed a persistent problem, multiple interest rate hikes may be necessary, but rate hikes are definitely not the only outcome. The central bank is prepared to adjust monetary policy as needed. Meanwhile, the Canadian economy is progressing steadily through a new phase in the trade dispute, but new US tariffs will put pressure on fourth-quarter economic growth. Macklem also noted that some spillover effects from global bond yields on Canada have been observed, which the central bank will take into account; if monetary policy fails to achieve its objectives, the market will repric.Delta Air Lines (DAL.N): This year it will invest approximately $18 billion in its employees through a “comprehensive incentive” program.Market news: Venezuelan interim president Rodriguez met with Eni CEO Descalzi.Delta Air Lines: It will match the donations made by eligible employees’ children with the same amount as the $1,000 that the federal government has paid into Trump’s related accounts.

Goldman Sachs Has Improved Humana's Competitive Standing

Aria Thomas

Dec 14, 2022 10:41

2.png


Goldman Sachs analysts upgraded shares of Humana (NYSE:HUM) to Buy with a $652 price target in a research note published on Tuesday.


The company's improved "competitive positioning in MA and underappreciated HC Services opportunity should outweigh the potential RADV impact," which Goldman Sachs estimates to range between $2.6 and $5.8 billion (NPV) before offsetting factors.


Analysts stated, "We see a strengthening earnings outlook as a result of improved competitive positioning in Massachusetts, which has reaccelerated member growth for 2023 and could lead to multiple years of share gains in 2024 when many competitors will face Stars headwinds." "We also see an attractive and undervalued opportunity in the health care services sector, with primary care earnings having the potential to outperform its September guidance,"


While analysts assert that the company is aware of the significant risk posed by the forthcoming RADV ruling, their EPS estimates for 2024-2025 are 4% higher than the industry average.


This reflects "3% higher member growth and a primary care EBITDA opportunity of $205mn-$395mn for 2025," which is "above the company's $100-$200mn outlook in its mid-term guidance, with more of this EBITDA hitting the P&L as WCAS centers come onto the balance sheet."


"Despite the stock's outperformance in 2022 (+18% YTD vs. MCO group +13%), the stock trades in line with its historical median despite higher forward EPS CAGR of 15% vs. its 3-year history of 12%," concluded the analysts.